Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 9,193-9,204 of 10,661

Drug study icon

CompletedNCT00553319

Adderall-XR for Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: ADHD

Drug study icon

CompletedNCT00036127

Alternate Formulation of Aripiprazole in Agitated people with Schizophrenic Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 18 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Drug study icon

TerminatedNCT00975611

Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: David C. Henderson, MD
Condition: Schizophrenia

Drug study icon

CompletedNCT00287352

Amantadine for Weight Stabilization During Olanzapine Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of North Carolina, Chapel Hill
Condition: Schizophrenia

Drug study icon

CompletedNCT00086593

An FDA-approved Drug As Additional Therapy In people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, Canada, United Kingdom
Sponsor: GlaxoSmithKline
Condition: Schizophrenia

Drug study icon

CompletedNCT00221962

Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 8 Years to 12 Years

Countries: United States
Sponsor: University Hospitals Cleveland Medical Center
Condition: ADHD

Drug study icon

CompletedNCT00194077

Aripiprazole (Abilify) in Children With Symptoms of Mania

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 4 Years to 9 Years

Countries: United States
Sponsor: University Hospitals Cleveland Medical Center
Condition: Bipolarity

Drug study icon

CompletedNCT00194012

Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 5 Years to 17 Years

Countries: United States
Sponsor: University Hospitals Cleveland Medical Center
Condition: Bipolarity

Drug study icon

CompletedNCT00036348

Aripiprazole in people with a History of Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugOver 18 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Bipolarity

Drug study icon

CompletedNCT00097266

Aripiprazole in people with Acute Bipolar Mania

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugOver 18 Years

Countries: United States, Bulgaria, Croatia, ...
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Bipolarity

Drug study icon

CompletedNCT00257972

Aripiprazole in people with Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugOver 18 Years

Countries: United States, Australia, France, ...
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Bipolarity

Drug study icon

CompletedNCT00080314

Aripiprazole in people with Bipolarity type I With a Major Depression Episode

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Bipolarity, Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.